Sorted By:

Relevance


Zika Virus: Current Outbreak and Ongoing Research Efforts

PhRMA  |  Report

Symptoms of the disease are usually mild, including fever, joint pain, rashes, and viral conjunctivitis (red/itchy eyes), and appear within a week of being exposed.
https://www.phrma.org/report/zika-virus-current-outbreak-and-ongoing-research-efforts

Collaboration Is Key in Researching and Developing New Medicines

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-2/collaboration-is-key-in-researching-and-developing-new-medicines

Aly Rusciano: My Life with Juvenile Arthritis and step therapy

Access Better Coverage  |  From Our Network

Except I couldn’t take that medication, which meant my body made the antibodies, and that treatment stopped working.
http://www.accessbettercoverage.org/social-news/aly-rusciano-my-life-with-juvenile-arthritis-and-step-therapy

Biomarkers and Surrogate Endpoints in Drug Development

From Hope To Cures  |  From Our Network

...
http://www.fromhopetocures.org/video/biomarkers-and-surrogate-endpoints-in-drug-development

Medicare Monday: More medicines in development for heart disease, stroke and other cardiovascular diseases

PhRMA  |  Blog Post

Food and Drug Administration (FDA).
http://catalyst.phrma.org/medicare-monday-more-medicines-in-development-for-heart-disease-stroke-and-other-cardiovascular-diseases

Nearly 200 Medicines in Development for Arthritis and Related Disorders, The Nation’s Most Common Cause of Disability

PhRMA  |  Press Release

  “Globally, millions of patients and healthcare professionals hope for better treatments to help ease the pain and suffering caused by arthritis and other musculoskeletal disorders,” said PhRMA President and CEO John J.
https://www.phrma.org/press-release/nearly-200-medicines-in-development-for-arthritis-and-related-disorders-the-nation-s-most-common-cause-of-disability

Celebrating brighter futures and healthier hearts during American Heart Month

PhRMA  |  Blog Post

Access to medicines through Medicare Part D coverage plays a key role in treating heart disease and stroke.
http://catalyst.phrma.org/celebrating-brighter-futures-and-healthier-hearts-during-american-heart-month

CSRxP proposals would undermine competitive market, harm patients and innovation

PhRMA  |  Blog Post

Data from insurers show prescription drug costs are a smaller share of premium increases than inpatient and outpatient hospitalizations, professional services or taxes and fees.
http://catalyst.phrma.org/csrxp-proposals-would-undermine-competitive-market-harm-patients-and-innovation

4 ways to better engage and empower patients

PhRMA  |  Blog Post

Instead, insurance plans should be transparent and held accountable for the clinical criteria they use to incentivize or discourage use of specific services and treatments.
http://catalyst.phrma.org/4-ways-to-better-engage-and-empower-patients

As U.S. looks to modernize NAFTA, strong enforcement of existing obligations should be a top priority

PhRMA  |  Blog Post

Maintaining strong policies will help promote the discovery of new medicines and support our economy and workforce.
http://catalyst.phrma.org/as-u.s.-looks-to-modernize-nafta-strong-enforcement-of-existing-obligations-should-be-a-top-priority

Patient voices missing from media conversation about prescription drug abuse

PhRMA  |  Blog Post

PhRMA strongly supports these efforts as part of our extensive policy recommendations to combat opioid abuse, which you can find explained in-depth here.
http://catalyst.phrma.org/patient-voices-missing-from-media-conversation-about-prescription-drug-abuse

Mounting Evidence Demonstrates the Potential for Savings and Improved Outcomes

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-6/mounting-evidence-demonstrates-the-potential-for-savings-and-improved-outcomes

Earlier and More Frequent Patent Challenges by Generic Companies

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-3/earlier-and-more-frequent-patent-challenges-by-generic-companies

Better Use of Medicines Yields Significant Health Gains and Savings on Other Services

Chartpack  |  From Our Network

Due to a growing body of evidence, in 2012 the Congressional Budget Office (CBO) began recognizing reductions in other medical expenditures associated with increased use of prescription medicines in Medicare that were not taken into account when CBO originally estimated Part D's cost....
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicare/better-use-of-medicines-yields-significant-health-gains-and-savings-on-other-services

Restrictive State Medicaid Preferred Drug Lists May Reduce Adherence and Lead to Poor Outcomes

Chartpack  |  From Our Network

In Alabama, 51% of patients discontinued statin therapy after preferred drug list (PDL) restrictions were imposed, compared to 39% in the previous period....
http://chartpack.phrma.org/programs-chartpack/medicines-in-medicaid/restrictive-state-medicaid-preferred-drug-lists-may-reduce-adherence-and-lead-to-poor-outcomes

The Challenge of Developing New Treatments and Cures

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/the-challenge-of-developing-new-treatments-and-cures

Celebrating hope for patients and families on World Heart Day 2016

PhRMA  |  Blog Post

Patients like my grandfather may live longer, more productive lives because of it – and we can share in it, one heartbeat at a time.
http://catalyst.phrma.org/celebrating-hope-for-patients-and-families-on-world-heart-day-2016

Helping Patients Drives America's Biopharmaceutical Researchers and Scientists

PhRMA  |  Video

Michael Rosenblatt, chief medical officer at Merck, along with countless others in the health care ecosystem, are working tirelessly each and every day to help address the remaining unmet medical needs for patients.
https://www.phrma.org/video/helping-patients-drives-america-s-biopharmaceutical-researchers-and-scientists

The US Prescription Drug Lifecycle Promotes Innovation and Affordability

Chartpack  |  From Our Network

Incredible advances by innovator pharmaceutical companies, resulting from pioneering scientific work and large-scale investments, eventually lead to lower cost generics that bring long-term value to consumers.
http://chartpack.phrma.org/biophrma-chartpack/spending-and-costs/the-us-prescription-drug-lifecycle-promotes-innovation-and-affordability

PPA connects nearly 10 million people; Celebrates 11th anniversary and launches mobile app

PhRMA  |  Blog Post

YouTube, and follow us on Facebook and Twitter.
http://catalyst.phrma.org/ppa-celebrates-11th-anniversary-and-launches-mobile-app

Challenges and opportunities in an era of personalized medicine

PhRMA  |  Blog Post

Private and public sector collaborations and the ability to maintain an ecosystem that supports and encourages innovation are key to driving continued progress in personalized medicine.
http://catalyst.phrma.org/challenges-and-opportunities-in-an-era-of-personalized-medicine

340B Drug Purchases and Population without Drug Coverage

PhRMA  |  Graphic

Drug purchases through the 340B program will continue to rise, at the same time the share of the population without prescription drug coverage will nearly drop in half....
https://www.phrma.org/graphic/trends-in-340b-drug-purchases-and-percent-of-total-population-without-prescription-drug-coverage

Key U.S. Health Industries Outline Six-Point Plan for Improved Health and Economic Growth in Asia-Pacific Region

PhRMA  |  Press Release

  In addition to endorsing the plan, the CEO’s of two major U.S. health care companies, Johnson and Johnson and Eli Lilly and Company, also congratulated APEC members on their progress to address Non-Communicable Diseases (NCDs) and achieve regulatory convergence, both components of the overall plan.
https://www.phrma.org/press-release/key-u-s-health-industries-outline-six-point-plan-for-improved-health-and-economic-growth-in-asia-pacific-region

Medicare Monday: Drug coverage before and after Medicare Part D

PhRMA  |  Blog Post

Today, nearly 40 million seniors and people living with disabilities benefit from the Part D program and numerous surveys have found 90 percent or more are satisfied with their coverage.
http://catalyst.phrma.org/medicare-monday-drug-coverage-before-and-after-medicare-part-d

Join “I’m Not Average,” a community for patients and supporters

PhRMA  |  Blog Post

And spread the message of hope using the .com/hashtag/ImNotAverage?
http://catalyst.phrma.org/join-im-not-average-a-community-for-patients-and-supporters

You have reviewed the first 275 results out of 2506. Each page contains 25 results. You're on page 11.

prev 7 8 9 10 11 12 next